Position in INCY
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$10,104,797
+$2,253,778 QoQ
Shares Held
89,139
+6.9% QoQ
Ownership
0.045%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#165
of 854 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Crossmark Global Holdings, Inc. holds $48,601,060 across 36 Biotechnology names. INCY ranks #1 (20.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
This page
|
89,139 | $10,104,797 | |
| 2 | ARGX |
Argenx SE
|
9,684 | $8,984,524 | |
| 3 | EXEL |
Exelixis, Inc.
|
74,817 | $4,070,792 | |
| 4 | ONC |
BeOne Medicines Ltd.
|
10,755 | $3,064,852 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
51,220 | $2,930,808 | |
| 6 | BNTX |
BioNTech SE
|
20,934 | $1,947,908 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
7,237 | $1,743,899 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,828 | $1,404,752 |
All Filings in INCY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,104,797 | 89,139 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $7,851,019 | 83,415 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $7,979,035 | 80,784 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $6,260,674 | 73,820 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $5,244,857 | 77,017 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $3,018,417 | 49,850 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $3,451,980 | 49,978 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $1,657,721 | 25,079 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $1,503,557 | 24,803 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $1,593,962 | 27,979 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,046,576 | 32,594 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,938,471 | 33,555 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,568,015 | 25,189 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $3,198,741 | 44,261 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,099,885 | 26,144 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $1,827,201 | 27,419 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $1,588,607 | 20,911 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $1,541,620 | 19,411 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $1,366,781 | 18,621 | Shares | Sole | 2022-01-10 | |
| 2021-09-30 | $1,282,127 | 18,641 | Shares | Sole | 2021-10-21 | |
| 2021-06-30 | $1,514,424 | 18,001 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $1,434,496 | 17,651 | Shares | Sole | 2021-04-15 | |
| 2020-12-31 | $1,633,571 | 18,781 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $2,549,603 | 28,411 | Shares | Sole | 2020-10-08 | |
| 2020-06-30 | $2,880,696 | 27,707 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $2,171,049 | 29,647 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||